NO791507L - Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetamin-derivater - Google Patents
Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetamin-derivaterInfo
- Publication number
- NO791507L NO791507L NO791507A NO791507A NO791507L NO 791507 L NO791507 L NO 791507L NO 791507 A NO791507 A NO 791507A NO 791507 A NO791507 A NO 791507A NO 791507 L NO791507 L NO 791507L
- Authority
- NO
- Norway
- Prior art keywords
- aminoamphetamin
- derivatives
- compounds
- manufacture
- intermediate products
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7312001A SE382047B (sv) | 1973-09-04 | 1973-09-04 | Forfarande for framstellning av 4-aminoamfetaminderivat |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO791507L true NO791507L (no) | 1975-03-05 |
| NO142624B NO142624B (no) | 1980-06-09 |
| NO142624C NO142624C (no) | 1980-09-17 |
Family
ID=20318423
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743177A NO139408C (no) | 1973-09-04 | 1974-09-04 | Analogifremgangsmaate til fremstilling av amfetaminderivater med anti-drepessiv og anxiolytisk effekt |
| NO791507A NO142624C (no) | 1973-09-04 | 1979-05-04 | Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743177A NO139408C (no) | 1973-09-04 | 1974-09-04 | Analogifremgangsmaate til fremstilling av amfetaminderivater med anti-drepessiv og anxiolytisk effekt |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3996381A (no) |
| JP (1) | JPS5835177B2 (no) |
| AT (1) | AT336566B (no) |
| BE (1) | BE819515A (no) |
| CA (1) | CA1051436A (no) |
| CH (2) | CH603547A5 (no) |
| DE (1) | DE2440734C2 (no) |
| DK (1) | DK139716B (no) |
| FI (1) | FI62281C (no) |
| FR (1) | FR2242079B1 (no) |
| GB (1) | GB1461667A (no) |
| HK (1) | HK75778A (no) |
| IE (1) | IE40514B1 (no) |
| LU (1) | LU70852A1 (no) |
| NL (1) | NL7411753A (no) |
| NO (2) | NO139408C (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2427388C (en) * | 2000-11-01 | 2011-12-20 | Sention, Inc. | Pharmaceutical compositions and uses for improving memory and learning impairments |
| US20070117869A1 (en) * | 2000-11-01 | 2007-05-24 | Cognition Pharmaceuticals Llc | Methods for treating coginitive impairment and improving cognition |
| US20050059743A1 (en) * | 2000-11-01 | 2005-03-17 | Sention, Inc. | Methods for treating mild cognitive impairment and alzheimer's disease |
| US7619005B2 (en) * | 2000-11-01 | 2009-11-17 | Cognition Pharmaceuticals Llc | Methods for treating cognitive impairment in humans with Multiple Sclerosis |
| US20030232890A1 (en) * | 2000-11-01 | 2003-12-18 | Sention, Inc. | Methods for treating an impairment in memory consolidation |
| US20030119884A1 (en) * | 2000-11-01 | 2003-06-26 | Epstein Mel H. | Methods and compositions for regulating memory consolidation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3117160A (en) * | 1961-07-27 | 1964-01-07 | Pfizer & Co C | Aralkylamines |
| US3496195A (en) * | 1966-05-11 | 1970-02-17 | Chinoin Gyogyszer Es Vegyeszet | D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts |
-
1974
- 1974-08-14 US US05/497,295 patent/US3996381A/en not_active Expired - Lifetime
- 1974-08-24 DE DE2440734A patent/DE2440734C2/de not_active Expired
- 1974-08-30 AT AT702574A patent/AT336566B/de not_active IP Right Cessation
- 1974-09-03 JP JP49100618A patent/JPS5835177B2/ja not_active Expired
- 1974-09-03 IE IE1824/74A patent/IE40514B1/xx unknown
- 1974-09-03 FI FI2576/74A patent/FI62281C/fi active
- 1974-09-03 DK DK464774AA patent/DK139716B/da not_active IP Right Cessation
- 1974-09-03 CA CA208,356A patent/CA1051436A/en not_active Expired
- 1974-09-03 CH CH1173577A patent/CH603547A5/xx not_active IP Right Cessation
- 1974-09-03 CH CH1195874A patent/CH599106A5/xx not_active IP Right Cessation
- 1974-09-03 GB GB3849974A patent/GB1461667A/en not_active Expired
- 1974-09-03 FR FR7429970A patent/FR2242079B1/fr not_active Expired
- 1974-09-04 NO NO743177A patent/NO139408C/no unknown
- 1974-09-04 BE BE148180A patent/BE819515A/xx not_active IP Right Cessation
- 1974-09-04 NL NL7411753A patent/NL7411753A/xx not_active Application Discontinuation
- 1974-09-04 LU LU70852A patent/LU70852A1/xx unknown
-
1978
- 1978-12-28 HK HK757/78A patent/HK75778A/xx unknown
-
1979
- 1979-05-04 NO NO791507A patent/NO142624C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK464774A (no) | 1975-05-05 |
| FI257674A (no) | 1975-03-05 |
| AT336566B (de) | 1977-05-10 |
| JPS5835177B2 (ja) | 1983-08-01 |
| FI62281B (fi) | 1982-08-31 |
| NO142624B (no) | 1980-06-09 |
| IE40514B1 (en) | 1979-06-20 |
| US3996381A (en) | 1976-12-07 |
| CH599106A5 (no) | 1978-05-12 |
| NL7411753A (nl) | 1975-03-06 |
| CH603547A5 (no) | 1978-08-31 |
| FR2242079A1 (no) | 1975-03-28 |
| JPS5050329A (no) | 1975-05-06 |
| GB1461667A (en) | 1977-01-19 |
| CA1051436A (en) | 1979-03-27 |
| AU7283374A (en) | 1976-03-04 |
| DE2440734C2 (de) | 1985-01-24 |
| FI62281C (fi) | 1982-12-10 |
| BE819515A (fr) | 1975-03-04 |
| IE40514L (en) | 1975-03-04 |
| DK139716C (no) | 1979-09-17 |
| DK139716B (da) | 1979-04-02 |
| LU70852A1 (no) | 1975-06-11 |
| NO139408C (no) | 1979-03-07 |
| DE2440734A1 (de) | 1975-03-13 |
| NO743177L (no) | 1975-04-01 |
| NO142624C (no) | 1980-09-17 |
| NO139408B (no) | 1978-11-27 |
| FR2242079B1 (no) | 1978-07-21 |
| HK75778A (en) | 1979-01-05 |
| ATA702574A (de) | 1976-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE423631B (sv) | Forfarande for framstellning av oxaalhyl-dialkylxantiner | |
| SE409707B (sv) | Forfarande for framstellning av sulfoxider, vilka er antagonister mot vissa verkningar av histamin | |
| NO143747C (no) | Carboxyalkylestere av n-fosfonmethylglycin for anvendelse som herbicide midler | |
| SE7710599L (sv) | Forfarande for framstellning av bensisoxazoler | |
| NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
| SE420604B (sv) | Forfarande for framstellning av oxazolderivat | |
| NO792681L (no) | 3-klor-7-alfa-aminoacylcefalosporinforbindelser for anvendelse som mellomprodukter ved fremstilling av cefalosporinderivater | |
| SE420598B (sv) | Analogiforfarande for framstellning av naftalenderivat | |
| NO143531C (no) | Fremgangsmaate for fremstilling av acylerte benzoksazolinon-derivater. | |
| SE7712151L (sv) | Forfarande for framstellning av linkomycinderivat | |
| NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
| NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
| SE417601B (sv) | Forfarande for framstellning av amidinokarbamider | |
| SE417958B (sv) | Azetidinderivat for anvendning som mellanprodukt for framstellning av delta?723-desacetoxicefalosporansyraderivat och framstellning av azetidinderivat | |
| NO843825L (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin | |
| NO791507L (no) | Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetamin-derivater | |
| SE7613500L (sv) | Forfarande for framstellning av cefemderivat | |
| NO148376C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser | |
| SE409994B (sv) | Forfarande for framstellning av amidinokarbamider | |
| SE401835B (sv) | Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on | |
| NO143845C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-amino-pyrrolderivater | |
| NO144018C (no) | Fremgangsmaate for fremstilling av heterocykliske forbindelser | |
| SE407687B (sv) | Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat | |
| AR209281A1 (es) | Procedimiento de preparacion de derivados de ciclopropilfenilpirrolidina | |
| SE409325B (sv) | Forfarande for framstellning av kinazolinonderivat |